Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy

BACKGROUND/AIMS: Preventing and treating proliferative vitreoretinopathy (PVR) remain a serious challenge for vitreoretinal surgeons. PVR is a devastating complication of retinal detachment that results in recurrent detachment and limits visual recovery. At present, there is no effective treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales: Benner, Jeffrey David, Dao, David, Butler, John W, Hamill, Kelli I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528755/
https://www.ncbi.nlm.nih.gov/pubmed/31179399
http://dx.doi.org/10.1136/bmjophth-2019-000293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528755/
https://www.ncbi.nlm.nih.gov/pubmed/31179399
http://dx.doi.org/10.1136/bmjophth-2019-000293

Ejemplares similares